These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 21994316)

  • 1. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.
    Bardage C; Persson I; Ortqvist A; Bergman U; Ludvigsson JF; Granath F
    BMJ; 2011 Oct; 343():d5956. PubMed ID: 21994316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
    Granath F; Gedeborg R; Smedje H; Feltelius N
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1045-1053. PubMed ID: 31062443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Pandemic Influenza A(H1N1) Vaccination in Pregnancy and Early Childhood Morbidity in Offspring.
    Hviid A; Svanström H; Mølgaard-Nielsen D; Lambach P
    JAMA Pediatr; 2017 Mar; 171(3):239-248. PubMed ID: 27893898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
    De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G
    JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and Narcolepsy.
    Stowe J; Andrews N; Miller E
    CNS Drugs; 2020 Jan; 34(1):1-8. PubMed ID: 31576507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.
    Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC
    PLoS One; 2014; 9(1):e82222. PubMed ID: 24404128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews.
    Juvet LK; Robertson AH; Laake I; Mjaaland S; Trogstad L
    Front Immunol; 2021; 12():740048. PubMed ID: 34777351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
    Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE
    Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.
    Ahmed SS; Schur PH; MacDonald NE; Steinman L
    J Autoimmun; 2014 May; 50():1-11. PubMed ID: 24559657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
    Wijnans L; Dodd CN; Weibel D; Sturkenboom M
    PLoS One; 2017; 12(5):e0175539. PubMed ID: 28467420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.
    Andrews N; Stowe J; Al-Shahi Salman R; Miller E
    Vaccine; 2011 Oct; 29(45):7878-82. PubMed ID: 21875631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.
    Li X; Raventós B; Roel E; Pistillo A; Martinez-Hernandez E; Delmestri A; Reyes C; Strauss V; Prieto-Alhambra D; Burn E; Duarte-Salles T
    BMJ; 2022 Mar; 376():e068373. PubMed ID: 35296468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis.
    Miller E; Andrews N; Stellitano L; Stowe J; Winstone AM; Shneerson J; Verity C
    BMJ; 2013 Feb; 346():f794. PubMed ID: 23444425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza.
    Ortqvist A; Bennet R; Rinder MR; Lindblad H; Eriksson M
    Vaccine; 2012 Aug; 30(39):5699-702. PubMed ID: 22819987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu
    Hall GC; Davies PTG; Karim MY; Haag MDM; O'Leary C
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):52-58. PubMed ID: 29152808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010.
    O'Flanagan D; Barret AS; Foley M; Cotter S; Bonner C; Crowe C; Lynch B; Sweeney B; Johnson H; McCoy B; Purcell E
    Euro Surveill; 2014 May; 19(17):15-25. PubMed ID: 24821121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.